Literature DB >> 27651688

Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction.

Paul H Sugarbaker1.   

Abstract

The purpose of this manuscript is to critically evaluate the preoperative assessments of peritoneal metastases described to date. Recommendations regarding use of current modalities and an assessment of their reliability will be made.

Entities:  

Keywords:  CT; Concerning radiologic features; MRI; PET; Peritoneal metastases normograms; SPDSS; Signet ring cells

Year:  2016        PMID： 27651688      PMCID： PMC5016333          DOI： 10.1007/s13193-016-0518-0

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  20 in total

1.  Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.

Authors:  Rodrigo Gomes da Silva; Paul H Sugarbaker
Journal:  J Am Coll Surg       Date:  2006-10-25       Impact factor: 6.113

2.  Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.

Authors:  Emel Canbay; Akiyoshi Mizumoto; Masumi Ichinose; Haruaki Ishibashi; Shouzou Sako; Masamitsu Hirano; Nobuyuki Takao; Yutaka Yonemura
Journal:  Ann Surg Oncol       Date:  2013-12-20       Impact factor: 5.344

3.  Evaluation of preoperative computed tomography in estimating peritoneal cancer index in peritoneal carcinomatosis.

Authors:  Lu Chang-Yun; Yutaka Yonemura; Haruaki Ishibashi; Shouzou Sako; Goro Tsukiyama; Toshiyuki Kitai; Nobuo Matsuki
Journal:  Gan To Kagaku Ryoho       Date:  2011-11

4.  Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis.

Authors:  Ju-Li Koh; Tristan D Yan; Derek Glenn; David L Morris
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

5.  Evaluation of computed tomography in patients with peritoneal carcinomatosis.

Authors:  P Jacquet; J S Jelinek; M A Steves; P H Sugarbaker
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

6.  Peritonectomy procedures.

Authors:  P H Sugarbaker
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

7.  Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.

Authors:  V J Verwaal; H van Tinteren; S van Ruth; F A N Zoetmulder
Journal:  Br J Surg       Date:  2004-06       Impact factor: 6.939

8.  Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival.

Authors:  Lana Bijelic; Anjali S Kumar; O Anthony Stuart; Paul H Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-07-26       Impact factor: 2.260

9.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Authors:  Xiao-Jun Yang; Chao-Qun Huang; Tao Suo; Lie-Jun Mei; Guo-Liang Yang; Fu-Lin Cheng; Yun-Feng Zhou; Bin Xiong; Yutaka Yonemura; Yan Li
Journal:  Ann Surg Oncol       Date:  2011-03-23       Impact factor: 5.344

10.  Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer.

Authors:  Rhonda L Harmon; Paul H Sugarbaker
Journal:  Int Semin Surg Oncol       Date:  2005-02-08
View more
  3 in total

1.  Accuracy of CT Scan in Predicting the Surgical PCI in Patients Undergoing Cytoreductive Surgery with/without HIPEC-a Prospective Single Institution Study.

Authors:  Gaurav Goswami; Praveen Kammar; Ramesh Mangal; Sakina Shaikh; Mahesh D Patel; Aditi Bhatt
Journal:  Indian J Surg Oncol       Date:  2019-03-28

Review 2.  Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies.

Authors:  Megan M Harper; Joseph Kim; Prakash K Pandalai
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

3.  Peritoneal carcinomatosis of unknown primary site may be an undiagnosed appendiceal adenocarcinoma. A case series.

Authors:  Paul H Sugarbaker
Journal:  Int J Surg Case Rep       Date:  2019-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.